| ID | 1639 | |
| PMID | 3298619 | |
| Year | 1987 | |
| Sequence | MALWMRLLPLLALLAL WGPDPAAAFVNQHLCGSH LVEALYLVCGERGFFYTPKTR REAEDLQVGQVELGGGPG AGSLQPLALEGSLQKRG IVEQCCTSICSLYQLENYCN | |
| Name | Insulin | |
| Length | 51 | |
| N-Terminal Modification | Free | |
| C-Terminal Modification | Free | |
| Linear/ Cyclic | Linear | |
| Chirality | L | |
| Chemical Modification | None | |
| Origin of Peptide | peptide hormone produced by beta cells of the pancreatic islets | |
| Nature of Peptide/Cargo | Not mentioned | |
| Mechanism | Not mentioned | |
| Cargo Sequence/Structure | No cargo | |
| Name of cargo | Not applicable | |
| Assay | Direct radioactive counting or the radio immunoassay of plasma | |
| Enhancer | Solution pH 3.68 | |
| Properties of enhancer | Not mentioned | |
| Concentration | Reservoir electrode was filled with 3ml of aqueous insulin solution. | |
| Incubation time | 20 minutes | |
| Tissue permeability (value with units) | Glucose level decreased from 295 mg/dL to 292 mg/dL | |
| Tissue Sample | Skin of 50 hairless rats and 12 regular rats. | |
| Ex vivo/In vivo/In vitro | in vitro | |
| STRUCTURE |
| |
| SMILES | N[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H] (C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H] (C(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O) N1[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) NCC(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@@H] 3C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC (=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H] (C(=O)N4[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H] (C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N [C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H] (C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)NCC(=O)NCC(=O)NCC(=O)N5[C@H](C(=O)NCC(=O)N[C@H] (C(=O)NCC(=O)N[C@H]( | |